MXPA04007117A - A nucleic acid encoding a g-protein-coupled receptor, and uses thereof. - Google Patents

A nucleic acid encoding a g-protein-coupled receptor, and uses thereof.

Info

Publication number
MXPA04007117A
MXPA04007117A MXPA04007117A MXPA04007117A MXPA04007117A MX PA04007117 A MXPA04007117 A MX PA04007117A MX PA04007117 A MXPA04007117 A MX PA04007117A MX PA04007117 A MXPA04007117 A MX PA04007117A MX PA04007117 A MXPA04007117 A MX PA04007117A
Authority
MX
Mexico
Prior art keywords
coupled receptor
protein
nucleic acid
acid encoding
receptor
Prior art date
Application number
MXPA04007117A
Other languages
Spanish (es)
Inventor
Sandrasagra Anthony
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0210597.1A external-priority patent/GB0210597D0/en
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MXPA04007117A publication Critical patent/MXPA04007117A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Provided herein is a novel and useful G-protein coupled receptor that is involved in signal transduction with respect to inflammation and physiological immunological response. Also provided are methods of using the receptor to screen for molecules that may modulate the activity of the receptor. Such molecules may readily have applications in treating a plethora of inflammation and immunologically related diseases and disorders.
MXPA04007117A 2002-01-23 2003-01-21 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof. MXPA04007117A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35100602P 2002-01-23 2002-01-23
GBGB0210597.1A GB0210597D0 (en) 2002-01-23 2002-05-09 A nucleic acid encoding a G-protein-coupled receptor,and uses thereof
PCT/US2003/001694 WO2003061365A2 (en) 2002-01-23 2003-01-21 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof

Publications (1)

Publication Number Publication Date
MXPA04007117A true MXPA04007117A (en) 2005-02-25

Family

ID=27614811

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04007117A MXPA04007117A (en) 2002-01-23 2003-01-21 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof.

Country Status (8)

Country Link
EP (1) EP1470420A4 (en)
JP (1) JP2005514934A (en)
BR (1) BR0307122A (en)
CA (1) CA2473707A1 (en)
MX (1) MXPA04007117A (en)
NO (1) NO20043123L (en)
RU (1) RU2004125608A (en)
WO (1) WO2003061365A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083388A2 (en) 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001031014A2 (en) * 1999-10-27 2001-05-03 Pharmacia & Upjohn Company G protein-coupled receptors expressed in human brain
EP1242448A2 (en) * 1999-11-17 2002-09-25 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
AU6604901A (en) * 2000-06-05 2001-12-17 Bayer Aktiengesellschaft Regulation of human hm74-like g protein coupled receptor

Also Published As

Publication number Publication date
RU2004125608A (en) 2005-04-20
WO2003061365A2 (en) 2003-07-31
EP1470420A2 (en) 2004-10-27
CA2473707A1 (en) 2003-07-31
BR0307122A (en) 2004-12-28
JP2005514934A (en) 2005-05-26
NO20043123L (en) 2004-07-20
EP1470420A4 (en) 2005-08-24
WO2003061365A3 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
HUP0203567A2 (en) April receptor (bcma) and uses thereof
ATE394121T1 (en) USE OF ANTIBODIES AGAINST THE MUC18 ANTIGEN
YU10602A (en) Use of baff receptors of imunoregulatory agent
MY137053A (en) Pyrimidine derivatives and their use as cb2 modulators
DE60234616D1 (en) SUBSTITUTED PIPERIDINES WITH SELECTIVE BINDING ABILITY TO HISTAMINE H3 RECEPTORS
MX9709324A (en) THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES.
AU2003254177A1 (en) Substituted benzanilides as modulators of the ccr5 receptor
PH12012501089A1 (en) Therapeutic human anti-il-1r1 monoclonal antibody
AU2003256923A1 (en) Substituted benzanilides as modulators of the ccr5 receptor
ATE347594T1 (en) MONOCYTE PROTEIN RECEPTORS FROM MAMMALS, WITH CHEMOATTRACTION TRIGGERING EFFECT
PL398596A1 (en) Preparation containing human antibodies for the treatment of disorders associated with TNF-α
HUP0401925A2 (en) A2b adenosine receptor antagonists
HK1073653A1 (en) Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates and method of preparation
DE69930835D1 (en) BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
WO2003057837A3 (en) Methods for using anti-muc18 antibodies
NO20004527D0 (en) Modulators for protein tyrosine phosphatases (PTPases)
AP2002002605A0 (en) Il-8 receptor antagonists
WO2001031014A3 (en) G protein-coupled receptors expressed in human brain
MXPA04007006A (en) A nucleic acid encoding a g-protein-coupled receptor, and uses thereof.
WO2004110385A3 (en) Modulators of the glucocorticoid receptor and method
AU2003255355A1 (en) Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
MXPA04007117A (en) A nucleic acid encoding a g-protein-coupled receptor, and uses thereof.
BR9807085A (en) Il-8 receptor antagonists
MXPA04004434A (en) A nucleic acid encoding a g-protein-coupled receptor, and uses thereof.
WO2001037874A3 (en) Treatment of psoriasis by using an antibody to tnf alpha